Ke Peng
- Biological Psychiatry top 10%
-
- Nanoplatforms for cancer theranostics 4
-
- Adipose Tissue and Metabolism 4
-
- MicroRNA in disease regulation 3
-
- Heart Failure Treatment and Management 3
- Cardiac pacing and defibrillation studies 2
- Cardiovascular Function and Risk Factors 2
-
- Advanced Drug Delivery Systems 3
-
- Anesthesia and Pain Management 2
- Journals
- American Journal of Hypertension (2 papers)PeerJ (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ke Peng
42 papers receiving 598 citations
Peers
Comparison fields: 5 of 104
- Biological Psychiatry 39
- Behavioral Neuroscience 18
- Immunology 95
- Neurology 37
- Developmental Neuroscience 17
Countries citing papers authored by Ke Peng
This map shows the geographic impact of Ke Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Peng more than expected).
Fields of papers citing papers by Ke Peng
This network shows the impact of papers produced by Ke Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Peng. The network helps show where Ke Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ke Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 25 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 17 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2019 | 13 | |
| 18 | 2018 | 17 | |
| 19 | 2016 | 14 | |
| 20 | 2015 | 72 |
About Ke Peng
Ke Peng is a scholar working on Applied Microbiology and Biotechnology, Pharmaceutical Science and Physiology, having authored 47 papers that have together received 606 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Adipose Tissue and Metabolism (4 papers), MicroRNA in disease regulation (3 papers), Heart Failure Treatment and Management (3 papers), Advanced Drug Delivery Systems (3 papers), Cardiac pacing and defibrillation studies (2 papers), Anesthesia and Pain Management (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Biological Psychiatry (39 citations), Behavioral Neuroscience (18 citations) and Immunology (95 citations). Ke Peng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hua Yang, Weidong Xiao, Yuan Qiu, Yuan Qiu, Min Yu, Chao Xu, Tao Ji, Lihua Sun, Min Han and Hua Yang. Their work appears in journals such as American Journal of Hypertension, PeerJ, International Journal of Pharmaceutics, Digestive Diseases and Sciences and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.